Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

Hans-Guido Wendel

Towards the Chemotherapy-Free Treatment of Follicular Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Corey Casper

Treatment Outcomes and Survival After a Diagnosis of Endemic Burkitt Lymphoma in Uganda

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Christine F Skibola

Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Robert Lowsky

BMT Clinical Trial Network at Stanford

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

John A Bartlett

Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies

Non-Hodgkin lymphoma Kaposi sarcoma Hodgkin lymphoma Cervix uteri All cancers but non-melanoma skin cancer

Venee Tubman

Pilot Neonatal Program for the Diagnosis and Surveillance of Sickle Cell Disease

Sarcoma Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma Hodgkin lymphoma